20210316 - Monitoring effects of Pexep Cr 12.5

Index of Journals

20210316 1256

1256: 1 tablet ingested.

Tablet name: Pexep Cr 12.5
Salt information:
Paroxetine Hydrochloride (from the back of the strip)
Paroxetine - 12.5 mg [Read the end notes]

Pexep CR 12.5 Tablet is a type of antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) group of medicines. 

1300:
The feeling right now is that for 2 to 3 hours, I would not be able to feel good.
That is because this antidepressant (like Antipsychotics) does something to your:
1. Thoughts
2. Your attention
3. Your feelings

1305: 
Nothing as of now. Only the anticipatory feeling of what is about to come.

1308:
 1. I have only been staring at this screen.
 2. My mouth feels dry.

1310:
 10-12 sips of water.

1318:
 In the past 8 minutes or so, I had a lot of fleeting thoughts about a lot of people. Nothing specific that I thought required me to pay attention or focus to, or even write about.

1321:
Forgot to mention: I had also taken 500 mg Paracetamol (acetaminophen) along with Pexep Cr 12.5.
This was for headache.

1332:
Nothing as such till now.

1334: 
 1. 10-12 sips of water. 
 2. Restroom visit.

1344:
 Nothing as such till now.

1554:
 Nothing negative ever after.
 Rather felt better.

End Notes

Ref: pubchem.ncbi.nlm.nih.gov

PubChem is a database of chemical molecules and their activities against biological assays. The system is maintained by the National Center for Biotechnology Information (NCBI), a component of the National Library of Medicine, which is part of the United States National Institutes of Health (NIH).

NCBI: National Center for Biotechnology information
NLM: National Library of Medicine
NIH: National Institues of Health

Paroxetine Hydrochloride is the hydrochloride salt form of paroxetine, a phenylpiperidine derivative and a selective serotonin reuptake inhibitor (SSRI) with antidepressant and anxiolytic properties. Paroxetine binds to the pre-synaptic serotonin transporter complex resulting in negative allosteric modulation of the complex thereby blocking reuptake of serotonin by the pre-synaptic transporter. Inhibition of serotonin recycling enhances serotonergic function through serotonin accumulation in the synaptic cleft, resulting in long-term desensitization and downregulation of 5HT1 (serotonin) receptors and leading to symptomatic relief of depressive illness.

Tags: Journal,Technology,Science,Behavioral Science,Medicine,Emotional Intelligence,Psychology,